NASDAQ : HCM
HUTCHMED (China) Limited — Key statistics
Healthcare · Drug Manufacturers - Specialty & Generic · Hong Kong
Last price 13.15 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 2.31B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 2.34B |
| Enterprise Value | 1.06B |
Dates
| Measure | Value |
|---|
| Earnings Date | Jul 30, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | n/a |
| Shares Outstanding | 869.07M |
| Shares Change (YoY) | +0.02% |
| Shares Change (QoQ) | -0.04% |
| Owned by Insiders (%) | 0.97% |
| Owned by Institutions (%) | 19.50% |
| Float | 528.06M |
Ratios
| Measure | Value |
|---|
| PE Ratio | 130.60 |
| Forward PE | 36.05 |
| PS Ratio | 4.20 |
| Forward PS | 3.35 |
| PB Ratio | 1.81 |
| P/TBV Ratio | 1.83 |
| P/FCF Ratio | 231.71 |
| P/OCF Ratio | 112.67 |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | 57.33 |
| EV / Sales | 1.87 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 103.05 |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 5.64 |
| Quick Ratio | 5.45 |
| Debt / Equity | 0.07 |
| Debt / EBITDA | n/a |
| Debt / FCF | 9.50 |
| Interest Coverage | -12.14 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | 1.46% |
| Return on Assets (ROA) | -1.24% |
| Return on Invested Capital (ROIC) | -1.60% |
| Return on Capital Employed (ROCE) | -2.38% |
| Weighted Average Cost of Capital (WACC) | 6.10% |
| Revenue Per Employee | $306,772 |
| Profits Per Employee | $9,991 |
| Employee Count | 1,790 |
| Asset Turnover | 0.31 |
| Inventory Turnover | 10.66 |
Taxes
| Measure | Value |
|---|
| Income Tax | 1.66M |
| Effective Tax Rate | 8.25% |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 0.36 |
| 52-Week Price Change | -10.61% |
| 50-Day Moving Average | 13.65 |
| 200-Day Moving Average | 13.22 |
| Relative Strength Index (RSI) | 41.07 |
| Average Volume (20 Days) | 44,889 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 265,001 |
| Short Previous Month | 275,665 |
| Short % of Shares Out | 0.25% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 4.66 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 549.12M |
| Gross Profit | 73.10M |
| Operating Income | -34.78M |
| Pretax Income | 20.08M |
| Net Income | 17.88M |
| EBITDA | -20.52M |
| EBIT | -34.78M |
| Earnings Per Share (EPS) | $0.10 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 1.38B |
| Total Debt | 94.51M |
| Net Cash | 1.28B |
| Net Cash Per Share | $1.48 |
| Equity (Book Value) | 1.27B |
| Book Value Per Share | 1.45 |
| Working Capital | 1.28B |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | 20.46M |
| Capital Expenditures | -10.51M |
| Depreciation & Amortization | 14.26M |
| Net Borrowing | -4.84M |
| Free Cash Flow | 9.95M |
| FCF Per Share | $0.01 |
Margins
| Measure | Value |
|---|
| Gross Margin | 13.31% |
| Operating Margin | -6.33% |
| Pretax Margin | 3.66% |
| Profit Margin | 3.26% |
| EBITDA Margin | -3.74% |
| EBIT Margin | -6.33% |
| FCF Margin | 1.81% |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -0.02% |
| Shareholder Yield | -0.02% |
| Earnings Yield | 0.77% |
| FCF Yield | 0.43% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $21.14 |
| Price Target Difference | 58.59% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 11 |
| Revenue Growth Forecast (3Y) | 12.59% |
| EPS Growth Forecast (3Y) | -47.01% |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 4.08 |
| Piotroski F-Score | 5 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside | |